{
    "medicine_id": "d25132ba2fb8cedc7cb2c62abbd4201116af7234",
    "platform_id": "DB09555",
    "metadata": {
        "name": "Abanatuss Ped 0 5 mg Tablet",
        "composition": "0 5 mg Dexchlorpheniramine maleate",
        "clinical_particulars": {
            "therapeutic_indications": "Dexchlorpheniramine can be used in the treatment of perennial and seasonal allergic rhinitis vasomotor rhiniti allergic conjunctivitis due to inhalant allergens and foods mild uncomplicated allergic skin manifestations of urticaria and angioedema amelioration of allergic reactions to blood or plasma and dermographism",
            "contraindications": {
                "disease": "Central nervous system depression",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "In allergic reactions an allergen binds to IgE antibodies on mast cells and basophils Once this occurs IgE receptors crosslink with each other triggering a series of events that eventually leads to cell degranulation and the release of histamine and other chemical mediators from the mast cell or basophil Histamine can react with local or widespread tissues through histamine receptors Histamine acting on H1 receptors produces pruritis vasodilatation hypotension flushing headache tachycardia and bronchoconstriction Histamine also increases vascular permeability and potentiates pain Dexchlorpheniramine is a histamine H1 antagonist of the alkylamine class It competes with histamine for the normal H1 receptor sites on effector cells of the gastrointestinal tract blood vessels and respiratory tract It provides effective temporary relief of sneezing watery and itchy eyes and runny nose due to hay fever and other upper respiratory allergies",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB09083",
                        "description": "Ivabradine may increase the QTc prolonging activities of Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00895",
                        "description": "Dexchlorpheniramine maleate may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent"
                    },
                    {
                        "drugbank-id": "DB06698",
                        "description": "The therapeutic efficacy of Betahistine can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00182",
                        "description": "Amphetamine may decrease the sedative and stimulatory activities of Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00191",
                        "description": "Phentermine may decrease the sedative and stimulatory activities of Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00865",
                        "description": "Benzphetamine may decrease the sedative and stimulatory activities of Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00937",
                        "description": "Diethylpropion may decrease the sedative and stimulatory activities of Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01255",
                        "description": "Lisdexamfetamine may decrease the sedative and stimulatory activities of Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01365",
                        "description": "Mephentermine may decrease the sedative and stimulatory activities of Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01442",
                        "description": "MMDA may decrease the sedative and stimulatory activities of Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01454",
                        "description": "Midomafetamine may decrease the sedative and stimulatory activities of Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01467",
                        "description": "2 5 Dimethoxy 4 ethylamphetamine may decrease the sedative and stimulatory activities of Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01484",
                        "description": "4 Bromo 2 5 dimethoxyamphetamine may decrease the sedative and stimulatory activities of Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01509",
                        "description": "Tenamfetamine may decrease the sedative and stimulatory activities of Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01556",
                        "description": "Chlorphentermine may decrease the sedative and stimulatory activities of Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01566",
                        "description": "Methylenedioxyethamphetamine may decrease the sedative and stimulatory activities of Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01576",
                        "description": "Dextroamphetamine may decrease the sedative and stimulatory activities of Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01577",
                        "description": "Metamfetamine may decrease the sedative and stimulatory activities of Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB09480",
                        "description": "Iofetamine I 123 may decrease the sedative and stimulatory activities of Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB12080",
                        "description": "Ritobegron may decrease the sedative and stimulatory activities of Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB13108",
                        "description": "Mephedrone may decrease the sedative and stimulatory activities of Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB13624",
                        "description": "Methoxyphenamine may decrease the sedative and stimulatory activities of Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB13703",
                        "description": "Gepefrine may decrease the sedative and stimulatory activities of Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB13940",
                        "description": "2 5 Dimethoxy 4 ethylthioamphetamine may decrease the sedative and stimulatory activities of Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00215",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Citalopram"
                    },
                    {
                        "drugbank-id": "DB00261",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Anagrelide"
                    },
                    {
                        "drugbank-id": "DB00280",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Disopyramide"
                    },
                    {
                        "drugbank-id": "DB00283",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Clemastine"
                    },
                    {
                        "drugbank-id": "DB00308",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Ibutilide"
                    },
                    {
                        "drugbank-id": "DB00313",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Valproic acid"
                    },
                    {
                        "drugbank-id": "DB00365",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Grepafloxacin"
                    },
                    {
                        "drugbank-id": "DB00539",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Toremifene"
                    },
                    {
                        "drugbank-id": "DB00619",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Imatinib"
                    },
                    {
                        "drugbank-id": "DB00685",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Trovafloxacin"
                    },
                    {
                        "drugbank-id": "DB00834",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Mifepristone"
                    },
                    {
                        "drugbank-id": "DB00875",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Flupentixol"
                    },
                    {
                        "drugbank-id": "DB00907",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Cocaine"
                    },
                    {
                        "drugbank-id": "DB01169",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Arsenic trioxide"
                    },
                    {
                        "drugbank-id": "DB01184",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Domperidone"
                    },
                    {
                        "drugbank-id": "DB01208",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Sparfloxacin"
                    },
                    {
                        "drugbank-id": "DB01244",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Bepridil"
                    },
                    {
                        "drugbank-id": "DB01267",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Paliperidone"
                    },
                    {
                        "drugbank-id": "DB01356",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01405",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Temafloxacin"
                    },
                    {
                        "drugbank-id": "DB01624",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Zuclopenthixol"
                    },
                    {
                        "drugbank-id": "DB04844",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Tetrabenazine"
                    },
                    {
                        "drugbank-id": "DB04946",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Iloperidone"
                    },
                    {
                        "drugbank-id": "DB05294",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Vandetanib"
                    },
                    {
                        "drugbank-id": "DB06176",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Romidepsin"
                    },
                    {
                        "drugbank-id": "DB06216",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Asenapine"
                    },
                    {
                        "drugbank-id": "DB06697",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Artemether"
                    },
                    {
                        "drugbank-id": "DB08881",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Vemurafenib"
                    },
                    {
                        "drugbank-id": "DB11730",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Ribociclib"
                    },
                    {
                        "drugbank-id": "DB11978",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB12161",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Deutetrabenazine"
                    },
                    {
                        "drugbank-id": "DB13074",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Macimorelin"
                    },
                    {
                        "drugbank-id": "DB13725",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Terodiline"
                    },
                    {
                        "drugbank-id": "DB09039",
                        "description": "The risk or severity of QTc prolongation can be increased when Eliglustat is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00908",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Quinidine"
                    },
                    {
                        "drugbank-id": "DB00204",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Dofetilide"
                    },
                    {
                        "drugbank-id": "DB00604",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Cisapride"
                    },
                    {
                        "drugbank-id": "DB01118",
                        "description": "The risk or severity of QTc prolongation can be increased when Amiodarone is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00007",
                        "description": "The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00014",
                        "description": "The risk or severity of QTc prolongation can be increased when Goserelin is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00195",
                        "description": "The risk or severity of QTc prolongation can be increased when Betaxolol is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00199",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00207",
                        "description": "The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00218",
                        "description": "The risk or severity of QTc prolongation can be increased when Moxifloxacin is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00263",
                        "description": "The risk or severity of QTc prolongation can be increased when Sulfisoxazole is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00343",
                        "description": "The risk or severity of QTc prolongation can be increased when Diltiazem is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00391",
                        "description": "The risk or severity of QTc prolongation can be increased when Sulpiride is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00393",
                        "description": "The risk or severity of QTc prolongation can be increased when Nimodipine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00420",
                        "description": "The risk or severity of QTc prolongation can be increased when Promazine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00433",
                        "description": "The risk or severity of QTc prolongation can be increased when Prochlorperazine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00450",
                        "description": "The risk or severity of QTc prolongation can be increased when Droperidol is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00537",
                        "description": "The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00544",
                        "description": "The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00556",
                        "description": "The risk or severity of QTc prolongation can be increased when Perflutren is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00568",
                        "description": "The risk or severity of QTc prolongation can be increased when Cinnarizine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00571",
                        "description": "The risk or severity of QTc prolongation can be increased when Propranolol is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00572",
                        "description": "The risk or severity of QTc prolongation can be increased when Atropine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00640",
                        "description": "The risk or severity of QTc prolongation can be increased when Adenosine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00738",
                        "description": "The risk or severity of QTc prolongation can be increased when Pentamidine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00743",
                        "description": "The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00748",
                        "description": "The risk or severity of QTc prolongation can be increased when Carbinoxamine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00757",
                        "description": "The risk or severity of QTc prolongation can be increased when Dolasetron is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00778",
                        "description": "The risk or severity of QTc prolongation can be increased when Roxithromycin is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00779",
                        "description": "The risk or severity of QTc prolongation can be increased when Nalidixic acid is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00827",
                        "description": "The risk or severity of QTc prolongation can be increased when Cinoxacin is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00889",
                        "description": "The risk or severity of QTc prolongation can be increased when Granisetron is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00904",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00922",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00933",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00967",
                        "description": "The risk or severity of QTc prolongation can be increased when Desloratadine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00978",
                        "description": "The risk or severity of QTc prolongation can be increased when Lomefloxacin is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00985",
                        "description": "The risk or severity of QTc prolongation can be increased when Dimenhydrinate is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01113",
                        "description": "The risk or severity of QTc prolongation can be increased when Papaverine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01114",
                        "description": "The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01115",
                        "description": "The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01137",
                        "description": "The risk or severity of QTc prolongation can be increased when Levofloxacin is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01155",
                        "description": "The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01165",
                        "description": "The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01193",
                        "description": "The risk or severity of QTc prolongation can be increased when Acebutolol is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01580",
                        "description": "The risk or severity of QTc prolongation can be increased when Oxprenolol is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01599",
                        "description": "The risk or severity of QTc prolongation can be increased when Probucol is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01615",
                        "description": "The risk or severity of QTc prolongation can be increased when Aceprometazine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB02638",
                        "description": "The risk or severity of QTc prolongation can be increased when Terlipressin is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB04825",
                        "description": "The risk or severity of QTc prolongation can be increased when Prenylamine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB04842",
                        "description": "The risk or severity of QTc prolongation can be increased when Fluspirilene is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB04948",
                        "description": "The risk or severity of QTc prolongation can be increased when Lofexidine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB04957",
                        "description": "The risk or severity of QTc prolongation can be increased when Azimilide is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB05223",
                        "description": "The risk or severity of QTc prolongation can be increased when Pracinostat is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB05488",
                        "description": "The risk or severity of QTc prolongation can be increased when Technetium Tc 99m ciprofloxacin is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB06160",
                        "description": "The risk or severity of QTc prolongation can be increased when Garenoxacin is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB06200",
                        "description": "The risk or severity of QTc prolongation can be increased when Tedisamil is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB06334",
                        "description": "The risk or severity of QTc prolongation can be increased when Tucidinostat is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB06402",
                        "description": "The risk or severity of QTc prolongation can be increased when Telavancin is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB06589",
                        "description": "The risk or severity of QTc prolongation can be increased when Pazopanib is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB06600",
                        "description": "The risk or severity of QTc prolongation can be increased when Nemonoxacin is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB06712",
                        "description": "The risk or severity of QTc prolongation can be increased when Nilvadipine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB08799",
                        "description": "The risk or severity of QTc prolongation can be increased when Antazoline is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB08865",
                        "description": "The risk or severity of QTc prolongation can be increased when Crizotinib is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB08903",
                        "description": "The risk or severity of QTc prolongation can be increased when Bedaquiline is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB08980",
                        "description": "The risk or severity of QTc prolongation can be increased when Fendiline is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB08992",
                        "description": "The risk or severity of QTc prolongation can be increased when Eperisone is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB09016",
                        "description": "The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB09063",
                        "description": "The risk or severity of QTc prolongation can be increased when Ceritinib is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB09078",
                        "description": "The risk or severity of QTc prolongation can be increased when Lenvatinib is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB09224",
                        "description": "The risk or severity of QTc prolongation can be increased when Melperone is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB09231",
                        "description": "The risk or severity of QTc prolongation can be increased when Benidipine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB11830",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Mocetinostat"
                    },
                    {
                        "drugbank-id": "DB11841",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Entinostat"
                    },
                    {
                        "drugbank-id": "DB12141",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Gilteritinib"
                    },
                    {
                        "drugbank-id": "DB12174",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with CUDC 101"
                    },
                    {
                        "drugbank-id": "DB12286",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Simendan"
                    },
                    {
                        "drugbank-id": "DB12376",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Ricolinostat"
                    },
                    {
                        "drugbank-id": "DB12523",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Mizolastine"
                    },
                    {
                        "drugbank-id": "DB12565",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Abexinostat"
                    },
                    {
                        "drugbank-id": "DB12877",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Oxatomide"
                    },
                    {
                        "drugbank-id": "DB13261",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Sitafloxacin"
                    },
                    {
                        "drugbank-id": "DB13273",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Sultopride"
                    },
                    {
                        "drugbank-id": "DB13500",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Otilonium"
                    },
                    {
                        "drugbank-id": "DB13546",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Nizofenone"
                    },
                    {
                        "drugbank-id": "DB13652",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Bunaftine"
                    },
                    {
                        "drugbank-id": "DB13653",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Lorcainide"
                    },
                    {
                        "drugbank-id": "DB13679",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Dexchlorpheniramine"
                    },
                    {
                        "drugbank-id": "DB13791",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Penfluridol"
                    },
                    {
                        "drugbank-id": "DB14063",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Dexverapamil"
                    },
                    {
                        "drugbank-id": "DB14568",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Ivosidenib"
                    },
                    {
                        "drugbank-id": "DB00625",
                        "description": "The risk or severity of QTc prolongation can be increased when Efavirenz is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00976",
                        "description": "The risk or severity of QTc prolongation can be increased when Telithromycin is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01211",
                        "description": "The risk or severity of QTc prolongation can be increased when Clarithromycin is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01227",
                        "description": "The risk or severity of QTc prolongation can be increased when Levacetylmethadol is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01232",
                        "description": "The risk or severity of QTc prolongation can be increased when Saquinavir is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01084",
                        "description": "The risk or severity of QTc prolongation can be increased when Emedastine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00104",
                        "description": "The risk or severity of QTc prolongation can be increased when Octreotide is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00107",
                        "description": "The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00187",
                        "description": "The risk or severity of QTc prolongation can be increased when Esmolol is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00188",
                        "description": "The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00196",
                        "description": "The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00230",
                        "description": "The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00245",
                        "description": "The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00270",
                        "description": "The risk or severity of QTc prolongation can be increased when Isradipine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00334",
                        "description": "The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00341",
                        "description": "The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00346",
                        "description": "The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00347",
                        "description": "The risk or severity of QTc prolongation can be increased when Trimethadione is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00354",
                        "description": "The risk or severity of QTc prolongation can be increased when Buclizine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00358",
                        "description": "The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00366",
                        "description": "The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00370",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirtazapine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00374",
                        "description": "The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00390",
                        "description": "The risk or severity of QTc prolongation can be increased when Digoxin is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00398",
                        "description": "The risk or severity of QTc prolongation can be increased when Sorafenib is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00405",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00424",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00427",
                        "description": "The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00434",
                        "description": "The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00467",
                        "description": "The risk or severity of QTc prolongation can be increased when Enoxacin is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00487",
                        "description": "The risk or severity of QTc prolongation can be increased when Pefloxacin is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00529",
                        "description": "The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00555",
                        "description": "The risk or severity of QTc prolongation can be increased when Lamotrigine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00613",
                        "description": "The risk or severity of QTc prolongation can be increased when Amodiaquine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00674",
                        "description": "The risk or severity of QTc prolongation can be increased when Galantamine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00678",
                        "description": "The risk or severity of QTc prolongation can be increased when Losartan is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00680",
                        "description": "The risk or severity of QTc prolongation can be increased when Moricizine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00691",
                        "description": "The risk or severity of QTc prolongation can be increased when Moexipril is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00697",
                        "description": "The risk or severity of QTc prolongation can be increased when Tizanidine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00710",
                        "description": "The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00714",
                        "description": "The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00719",
                        "description": "The risk or severity of QTc prolongation can be increased when Azatadine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00734",
                        "description": "The risk or severity of QTc prolongation can be increased when Risperidone is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00753",
                        "description": "The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00808",
                        "description": "The risk or severity of QTc prolongation can be increased when Indapamide is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00817",
                        "description": "The risk or severity of QTc prolongation can be increased when Rosoxacin is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00818",
                        "description": "The risk or severity of QTc prolongation can be increased when Propofol is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00822",
                        "description": "The risk or severity of QTc prolongation can be increased when Disulfiram is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00825",
                        "description": "The risk or severity of QTc prolongation can be increased when Levomenthol is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00835",
                        "description": "The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00871",
                        "description": "The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00909",
                        "description": "The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00916",
                        "description": "The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00920",
                        "description": "The risk or severity of QTc prolongation can be increased when Ketotifen is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00927",
                        "description": "The risk or severity of QTc prolongation can be increased when Famotidine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00934",
                        "description": "The risk or severity of QTc prolongation can be increased when Maprotiline is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00938",
                        "description": "The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00949",
                        "description": "The risk or severity of QTc prolongation can be increased when Felbamate is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00983",
                        "description": "The risk or severity of QTc prolongation can be increased when Formoterol is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00999",
                        "description": "The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01001",
                        "description": "The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01015",
                        "description": "The risk or severity of QTc prolongation can be increased when Sulfamethoxazole is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01036",
                        "description": "The risk or severity of QTc prolongation can be increased when Tolterodine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01044",
                        "description": "The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01054",
                        "description": "The risk or severity of QTc prolongation can be increased when Nitrendipine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01059",
                        "description": "The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01069",
                        "description": "The risk or severity of QTc prolongation can be increased when Promethazine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01071",
                        "description": "The risk or severity of QTc prolongation can be increased when Mequitazine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01106",
                        "description": "The risk or severity of QTc prolongation can be increased when Levocabastine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01158",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01166",
                        "description": "The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01176",
                        "description": "The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01189",
                        "description": "The risk or severity of QTc prolongation can be increased when Desflurane is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01228",
                        "description": "The risk or severity of QTc prolongation can be increased when Encainide is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01236",
                        "description": "The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01238",
                        "description": "The risk or severity of QTc prolongation can be increased when Aripiprazole is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01239",
                        "description": "The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01246",
                        "description": "The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01259",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01268",
                        "description": "The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01274",
                        "description": "The risk or severity of QTc prolongation can be increased when Arformoterol is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01426",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01591",
                        "description": "The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01611",
                        "description": "The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01620",
                        "description": "The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB02546",
                        "description": "The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB04576",
                        "description": "The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB04695",
                        "description": "The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB04846",
                        "description": "The risk or severity of QTc prolongation can be increased when Celiprolol is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB04953",
                        "description": "The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB05039",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB05246",
                        "description": "The risk or severity of QTc prolongation can be increased when Methsuximide is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB05465",
                        "description": "The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB06217",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB06282",
                        "description": "The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB06288",
                        "description": "The risk or severity of QTc prolongation can be increased when Amisulpride is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB06468",
                        "description": "The risk or severity of QTc prolongation can be increased when Cariporide is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB06663",
                        "description": "The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB06699",
                        "description": "The risk or severity of QTc prolongation can be increased when Degarelix is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB06719",
                        "description": "The risk or severity of QTc prolongation can be increased when Buserelin is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB06788",
                        "description": "The risk or severity of QTc prolongation can be increased when Histrelin is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB06825",
                        "description": "The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB07780",
                        "description": "The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB07841",
                        "description": "The risk or severity of QTc prolongation can be increased when Geranylgeranyl diphosphate is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB08808",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB08871",
                        "description": "The risk or severity of QTc prolongation can be increased when Eribulin is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB08912",
                        "description": "The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB08936",
                        "description": "The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB08952",
                        "description": "The risk or severity of QTc prolongation can be increased when Indenolol is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB08972",
                        "description": "The risk or severity of QTc prolongation can be increased when Flumequine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB09080",
                        "description": "The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB09082",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB09089",
                        "description": "The risk or severity of QTc prolongation can be increased when Trimebutine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB09090",
                        "description": "The risk or severity of QTc prolongation can be increased when Pinaverium is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB09229",
                        "description": "The risk or severity of QTc prolongation can be increased when Aranidipine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB09235",
                        "description": "The risk or severity of QTc prolongation can be increased when Efonidipine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB09236",
                        "description": "The risk or severity of QTc prolongation can be increased when Lacidipine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB09239",
                        "description": "The risk or severity of QTc prolongation can be increased when Niguldipine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB09488",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB11390",
                        "description": "The risk or severity of QTc prolongation can be increased when Coumaphos is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB11397",
                        "description": "The risk or severity of QTc prolongation can be increased when Dichlorvos is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB11408",
                        "description": "The risk or severity of QTc prolongation can be increased when Famphur is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB11412",
                        "description": "The risk or severity of QTc prolongation can be increased when Fenthion is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB11443",
                        "description": "The risk or severity of QTc prolongation can be increased when Orbifloxacin is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB11448",
                        "description": "The risk or severity of QTc prolongation can be increased when Phosmet is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB11491",
                        "description": "The risk or severity of QTc prolongation can be increased when Sarafloxacin is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB11511",
                        "description": "The risk or severity of QTc prolongation can be increased when Difloxacin is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB11591",
                        "description": "The risk or severity of QTc prolongation can be increased when Bilastine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB11614",
                        "description": "The risk or severity of QTc prolongation can be increased when Rupatadine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB11770",
                        "description": "The risk or severity of QTc prolongation can be increased when Talinolol is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB11774",
                        "description": "The risk or severity of QTc prolongation can be increased when Pazufloxacin is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB11785",
                        "description": "The risk or severity of QTc prolongation can be increased when Anisodamine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB11891",
                        "description": "The risk or severity of QTc prolongation can be increased when CUDC 907 is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB11892",
                        "description": "The risk or severity of QTc prolongation can be increased when Prulifloxacin is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB11943",
                        "description": "The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB12093",
                        "description": "The risk or severity of QTc prolongation can be increased when Tetrahydropalmatine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB12231",
                        "description": "The risk or severity of QTc prolongation can be increased when Temefos is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB12245",
                        "description": "The risk or severity of QTc prolongation can be increased when Triclabendazole is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB12645",
                        "description": "The risk or severity of QTc prolongation can be increased when Givinostat is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB12712",
                        "description": "The risk or severity of QTc prolongation can be increased when Pilsicainide is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB12766",
                        "description": "The risk or severity of QTc prolongation can be increased when Cicletanine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB12923",
                        "description": "The risk or severity of QTc prolongation can be increased when Gallopamil is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB13358",
                        "description": "The risk or severity of QTc prolongation can be increased when Cibenzoline is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB13488",
                        "description": "The risk or severity of QTc prolongation can be increased when Bencyclane is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB13555",
                        "description": "The risk or severity of QTc prolongation can be increased when Prajmaline is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB13627",
                        "description": "The risk or severity of QTc prolongation can be increased when Oxolinic acid is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB13651",
                        "description": "The risk or severity of QTc prolongation can be increased when Lorajmine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB13691",
                        "description": "The risk or severity of QTc prolongation can be increased when Acetyldigoxin is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB13744",
                        "description": "The risk or severity of QTc prolongation can be increased when Piromidic acid is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB13766",
                        "description": "The risk or severity of QTc prolongation can be increased when Lidoflazine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB13772",
                        "description": "The risk or severity of QTc prolongation can be increased when Rufloxacin is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB13823",
                        "description": "The risk or severity of QTc prolongation can be increased when Pipemidic acid is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB14185",
                        "description": "The risk or severity of QTc prolongation can be increased when Aripiprazole lauroxil is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB14713",
                        "description": "The risk or severity of QTc prolongation can be increased when Inotersen is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01623",
                        "description": "The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00373",
                        "description": "The risk or severity of QTc prolongation can be increased when Timolol is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00582",
                        "description": "The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00593",
                        "description": "The risk or severity of QTc prolongation can be increased when Ethosuximide is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00862",
                        "description": "The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00864",
                        "description": "The risk or severity of QTc prolongation can be increased when Tacrolimus is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01072",
                        "description": "The risk or severity of QTc prolongation can be increased when Atazanavir is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01167",
                        "description": "The risk or severity of QTc prolongation can be increased when Itraconazole is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01254",
                        "description": "The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01263",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01396",
                        "description": "The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB08815",
                        "description": "The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB11742",
                        "description": "The risk or severity of QTc prolongation can be increased when Ebastine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01601",
                        "description": "The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00344",
                        "description": "The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00915",
                        "description": "The risk or severity of QTc prolongation can be increased when Amantadine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00845",
                        "description": "The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB11796",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB11853",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00468",
                        "description": "The metabolism of Quinine can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB04868",
                        "description": "The metabolism of Nilotinib can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB06708",
                        "description": "The metabolism of Lumefantrine can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00363",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Clozapine"
                    },
                    {
                        "drugbank-id": "DB01087",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Primaquine"
                    },
                    {
                        "drugbank-id": "DB00285",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Venlafaxine"
                    },
                    {
                        "drugbank-id": "DB00622",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Nicardipine"
                    },
                    {
                        "drugbank-id": "DB00501",
                        "description": "The metabolism of Cimetidine can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00176",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Fluvoxamine"
                    },
                    {
                        "drugbank-id": "DB00349",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Clobazam"
                    },
                    {
                        "drugbank-id": "DB02703",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Fusidic acid"
                    },
                    {
                        "drugbank-id": "DB00705",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Delavirdine"
                    },
                    {
                        "drugbank-id": "DB01026",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Ketoconazole"
                    },
                    {
                        "drugbank-id": "DB00169",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Cholecalciferol"
                    },
                    {
                        "drugbank-id": "DB00264",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Metoprolol"
                    },
                    {
                        "drugbank-id": "DB00476",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Duloxetine"
                    },
                    {
                        "drugbank-id": "DB00477",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Chlorpromazine"
                    },
                    {
                        "drugbank-id": "DB00482",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Celecoxib"
                    },
                    {
                        "drugbank-id": "DB00608",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Chloroquine"
                    },
                    {
                        "drugbank-id": "DB00752",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Tranylcypromine"
                    },
                    {
                        "drugbank-id": "DB01074",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Perhexiline"
                    },
                    {
                        "drugbank-id": "DB01079",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Tegaserod"
                    },
                    {
                        "drugbank-id": "DB05812",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Abiraterone"
                    },
                    {
                        "drugbank-id": "DB06603",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Panobinostat"
                    },
                    {
                        "drugbank-id": "DB06684",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Vilazodone"
                    },
                    {
                        "drugbank-id": "DB06729",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Sulfaphenazole"
                    },
                    {
                        "drugbank-id": "DB06819",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Phenylbutyric acid"
                    },
                    {
                        "drugbank-id": "DB08893",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB09238",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Manidipine"
                    },
                    {
                        "drugbank-id": "DB09291",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Rolapitant"
                    },
                    {
                        "drugbank-id": "DB11586",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Asunaprevir"
                    },
                    {
                        "drugbank-id": "DB12332",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Rucaparib"
                    },
                    {
                        "drugbank-id": "DB12693",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Ritanserin"
                    },
                    {
                        "drugbank-id": "DB13174",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Rhein"
                    },
                    {
                        "drugbank-id": "DB00857",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Terbinafine"
                    },
                    {
                        "drugbank-id": "DB00091",
                        "description": "The metabolism of Cyclosporine can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00342",
                        "description": "The metabolism of Terfenadine can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00458",
                        "description": "The metabolism of Imipramine can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00496",
                        "description": "The metabolism of Darifenacin can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00932",
                        "description": "The metabolism of Tipranavir can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01151",
                        "description": "The metabolism of Desipramine can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB09167",
                        "description": "The metabolism of Dosulepin can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB04871",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Lorcaserin"
                    },
                    {
                        "drugbank-id": "DB15982",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Berotralstat"
                    },
                    {
                        "drugbank-id": "DB00679",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Thioridazine"
                    },
                    {
                        "drugbank-id": "DB00715",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Paroxetine"
                    },
                    {
                        "drugbank-id": "DB01012",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Cinacalcet"
                    },
                    {
                        "drugbank-id": "DB01173",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Orphenadrine"
                    },
                    {
                        "drugbank-id": "DB01182",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Propafenone"
                    },
                    {
                        "drugbank-id": "DB01218",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Halofantrine"
                    },
                    {
                        "drugbank-id": "DB01403",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Methotrimeprazine"
                    },
                    {
                        "drugbank-id": "DB08909",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Glycerol phenylbutyrate"
                    },
                    {
                        "drugbank-id": "DB06595",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Midostaurin"
                    },
                    {
                        "drugbank-id": "DB09343",
                        "description": "The excretion of Tipiracil can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB11637",
                        "description": "Dexchlorpheniramine maleate may increase the QTc prolonging activities of Delamanid"
                    },
                    {
                        "drugbank-id": "DB11642",
                        "description": "The therapeutic efficacy of Pitolisant can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01273",
                        "description": "The excretion of Varenicline can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00457",
                        "description": "The serum concentration of Prazosin can be increased when it is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB14754",
                        "description": "The serum concentration of Solriamfetol can be increased when it is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB08882",
                        "description": "The serum concentration of Linagliptin can be increased when it is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB14006",
                        "description": "The serum concentration of Choline salicylate can be increased when it is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00122",
                        "description": "The serum concentration of Choline can be increased when it is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00331",
                        "description": "The serum concentration of Metformin can be increased when it is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00368",
                        "description": "The serum concentration of Norepinephrine can be increased when it is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00206",
                        "description": "The serum concentration of Reserpine can be increased when it is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00413",
                        "description": "The serum concentration of Pramipexole can be increased when it is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00668",
                        "description": "The serum concentration of Epinephrine can be increased when it is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00709",
                        "description": "The serum concentration of Lamivudine can be increased when it is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00988",
                        "description": "The serum concentration of Dopamine can be increased when it is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01043",
                        "description": "The serum concentration of Memantine can be increased when it is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB05381",
                        "description": "The serum concentration of Histamine can be increased when it is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB08838",
                        "description": "The serum concentration of Agmatine can be increased when it is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB12598",
                        "description": "The serum concentration of Nafamostat can be increased when it is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB09046",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be increased when combined with Metreleptin"
                    },
                    {
                        "drugbank-id": "DB01224",
                        "description": "The metabolism of Quetiapine can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01037",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Selegiline"
                    },
                    {
                        "drugbank-id": "DB09061",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB14011",
                        "description": "The metabolism of Nabiximols can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00208",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Ticlopidine"
                    },
                    {
                        "drugbank-id": "DB00281",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Lidocaine"
                    },
                    {
                        "drugbank-id": "DB00412",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Rosiglitazone"
                    },
                    {
                        "drugbank-id": "DB00574",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Fenfluramine"
                    },
                    {
                        "drugbank-id": "DB00598",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Labetalol"
                    },
                    {
                        "drugbank-id": "DB00633",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Dexmedetomidine"
                    },
                    {
                        "drugbank-id": "DB00792",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Tripelennamine"
                    },
                    {
                        "drugbank-id": "DB00810",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Biperiden"
                    },
                    {
                        "drugbank-id": "DB00850",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Perphenazine"
                    },
                    {
                        "drugbank-id": "DB01005",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Hydroxyurea"
                    },
                    {
                        "drugbank-id": "DB01075",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Diphenhydramine"
                    },
                    {
                        "drugbank-id": "DB01128",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Bicalutamide"
                    },
                    {
                        "drugbank-id": "DB01171",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Moclobemide"
                    },
                    {
                        "drugbank-id": "DB01233",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Metoclopramide"
                    },
                    {
                        "drugbank-id": "DB01435",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Antipyrine"
                    },
                    {
                        "drugbank-id": "DB01621",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Pipotiazine"
                    },
                    {
                        "drugbank-id": "DB04818",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Iproniazid"
                    },
                    {
                        "drugbank-id": "DB04884",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Dapoxetine"
                    },
                    {
                        "drugbank-id": "DB05271",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Rotigotine"
                    },
                    {
                        "drugbank-id": "DB06204",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Tapentadol"
                    },
                    {
                        "drugbank-id": "DB06654",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Safinamide"
                    },
                    {
                        "drugbank-id": "DB06727",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Sparteine"
                    },
                    {
                        "drugbank-id": "DB00185",
                        "description": "The metabolism of Cevimeline can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00193",
                        "description": "The metabolism of Tramadol can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00289",
                        "description": "The metabolism of Atomoxetine can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00297",
                        "description": "The metabolism of Bupivacaine can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00335",
                        "description": "The metabolism of Atenolol can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00356",
                        "description": "The metabolism of Chlorzoxazone can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00377",
                        "description": "The metabolism of Palonosetron can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00379",
                        "description": "The metabolism of Mexiletine can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00409",
                        "description": "The metabolism of Remoxipride can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00497",
                        "description": "The metabolism of Oxycodone can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00589",
                        "description": "The metabolism of Lisuride can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00592",
                        "description": "The metabolism of Piperazine can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00699",
                        "description": "The metabolism of Nicergoline can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00706",
                        "description": "The metabolism of Tamsulosin can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00731",
                        "description": "The metabolism of Nateglinide can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00737",
                        "description": "The metabolism of Meclizine can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00805",
                        "description": "The metabolism of Minaprine can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00866",
                        "description": "The metabolism of Alprenolol can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00918",
                        "description": "The metabolism of Almotriptan can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00921",
                        "description": "The metabolism of Buprenorphine can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00956",
                        "description": "The metabolism of Hydrocodone can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00960",
                        "description": "The metabolism of Pindolol can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01028",
                        "description": "The metabolism of Methoxyflurane can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01136",
                        "description": "The metabolism of Carvedilol can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01177",
                        "description": "The metabolism of Idarubicin can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01191",
                        "description": "The metabolism of Dexfenfluramine can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01192",
                        "description": "The metabolism of Oxymorphone can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01203",
                        "description": "The metabolism of Nadolol can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01295",
                        "description": "The metabolism of Bevantolol can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01297",
                        "description": "The metabolism of Practolol can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01359",
                        "description": "The metabolism of Penbutolol can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01392",
                        "description": "The metabolism of Yohimbine can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01409",
                        "description": "The metabolism of Tiotropium can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01424",
                        "description": "The metabolism of Aminophenazone can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01429",
                        "description": "The metabolism of Aprindine can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01466",
                        "description": "The metabolism of Ethylmorphine can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01472",
                        "description": "The metabolism of 4 Methoxyamphetamine can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01551",
                        "description": "The metabolism of Dihydrocodeine can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB03783",
                        "description": "The metabolism of Phenacetin can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB04829",
                        "description": "The metabolism of Lysergic acid diethylamide can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB04840",
                        "description": "The metabolism of Debrisoquine can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB04841",
                        "description": "The metabolism of Flunarizine can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB04861",
                        "description": "The metabolism of Nebivolol can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB06016",
                        "description": "The metabolism of Cariprazine can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB06144",
                        "description": "The metabolism of Sertindole can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB06148",
                        "description": "The metabolism of Mianserin can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB06203",
                        "description": "The metabolism of Alogliptin can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB06292",
                        "description": "The metabolism of Dapagliflozin can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB06506",
                        "description": "The metabolism of Repinotan can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB06608",
                        "description": "The metabolism of Tafenoquine can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB06678",
                        "description": "The metabolism of Esmirtazapine can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB06702",
                        "description": "The metabolism of Fesoterodine can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB06726",
                        "description": "The metabolism of Bufuralol can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB06735",
                        "description": "The metabolism of Enclomiphene can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB06770",
                        "description": "The metabolism of Benzyl alcohol can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB08807",
                        "description": "The metabolism of Bopindolol can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB08918",
                        "description": "The metabolism of Levomilnacipran can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB08922",
                        "description": "The metabolism of Perospirone can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB09068",
                        "description": "The metabolism of Vortioxetine can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB09076",
                        "description": "The metabolism of Umeclidinium can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB09128",
                        "description": "The metabolism of Brexpiprazole can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB09183",
                        "description": "The metabolism of Dasabuvir can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB09195",
                        "description": "The metabolism of Lorpiprazole can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB09204",
                        "description": "The metabolism of Arotinolol can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB09351",
                        "description": "The metabolism of Levobetaxolol can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB11130",
                        "description": "The metabolism of Opium can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB11855",
                        "description": "The metabolism of Revefenacin can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB11915",
                        "description": "The metabolism of Valbenazine can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB11979",
                        "description": "The metabolism of Elagolix can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB12212",
                        "description": "The metabolism of Landiolol can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB12752",
                        "description": "The metabolism of Bucindolol can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB13293",
                        "description": "The metabolism of Ipecac can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB13443",
                        "description": "The metabolism of Esatenolol can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB13508",
                        "description": "The metabolism of Cloranolol can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB13530",
                        "description": "The metabolism of Mepindolol can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB13757",
                        "description": "The metabolism of Epanolol can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB13775",
                        "description": "The metabolism of Tertatolol can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB11638",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Artenimol"
                    },
                    {
                        "drugbank-id": "DB11994",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Diacerein"
                    },
                    {
                        "drugbank-id": "DB00843",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Donepezil"
                    },
                    {
                        "drugbank-id": "DB09173",
                        "description": "The metabolism of Butyrfentanyl can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB11757",
                        "description": "The metabolism of Istradefylline can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01410",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Ciclesonide"
                    },
                    {
                        "drugbank-id": "DB00220",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Nelfinavir"
                    },
                    {
                        "drugbank-id": "DB06691",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB00528",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Lercanidipine"
                    },
                    {
                        "drugbank-id": "DB09288",
                        "description": "The metabolism of Propacetamol can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01096",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Oxamniquine"
                    },
                    {
                        "drugbank-id": "DB01562",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with 1 2 Phenylethyl 4 phenyl 4 acetoxypiperidine"
                    },
                    {
                        "drugbank-id": "DB04889",
                        "description": "The metabolism of Bicifadine can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB14010",
                        "description": "The metabolism of 5 methoxy N N dimethyltryptamine can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB13139",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Levosalbutamol"
                    },
                    {
                        "drugbank-id": "DB00333",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Methadone"
                    },
                    {
                        "drugbank-id": "DB00439",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Cerivastatin"
                    },
                    {
                        "drugbank-id": "DB00647",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Dextropropoxyphene"
                    },
                    {
                        "drugbank-id": "DB00763",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Methimazole"
                    },
                    {
                        "drugbank-id": "DB00780",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Phenelzine"
                    },
                    {
                        "drugbank-id": "DB00972",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Azelastine"
                    },
                    {
                        "drugbank-id": "DB00997",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Doxorubicin"
                    },
                    {
                        "drugbank-id": "DB01023",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Felodipine"
                    },
                    {
                        "drugbank-id": "DB01062",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Oxybutynin"
                    },
                    {
                        "drugbank-id": "DB01093",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Dimethyl sulfoxide"
                    },
                    {
                        "drugbank-id": "DB01110",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Miconazole"
                    },
                    {
                        "drugbank-id": "DB01388",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Mibefradil"
                    },
                    {
                        "drugbank-id": "DB01590",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Everolimus"
                    },
                    {
                        "drugbank-id": "DB06370",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Indisulam"
                    },
                    {
                        "drugbank-id": "DB06412",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Oxymetholone"
                    },
                    {
                        "drugbank-id": "DB08864",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Rilpivirine"
                    },
                    {
                        "drugbank-id": "DB09049",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Naloxegol"
                    },
                    {
                        "drugbank-id": "DB09118",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Stiripentol"
                    },
                    {
                        "drugbank-id": "DB00203",
                        "description": "The metabolism of Sildenafil can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00216",
                        "description": "The metabolism of Eletriptan can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00238",
                        "description": "The metabolism of Nevirapine can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00316",
                        "description": "The metabolism of Acetaminophen can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00317",
                        "description": "The metabolism of Gefitinib can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00425",
                        "description": "The metabolism of Zolpidem can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00490",
                        "description": "The metabolism of Buspirone can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00641",
                        "description": "The metabolism of Simvastatin can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00701",
                        "description": "The metabolism of Amprenavir can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00836",
                        "description": "The metabolism of Loperamide can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01095",
                        "description": "The metabolism of Fluvastatin can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01149",
                        "description": "The metabolism of Nefazodone can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB04905",
                        "description": "The metabolism of Tesmilifene can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB04920",
                        "description": "The metabolism of Clevidipine can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB09048",
                        "description": "The metabolism of Netupitant can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB09053",
                        "description": "The metabolism of Ibrutinib can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB12070",
                        "description": "The metabolism of Letermovir can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB11633",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Isavuconazole"
                    },
                    {
                        "drugbank-id": "DB11753",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Rifamycin"
                    },
                    {
                        "drugbank-id": "DB13975",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Black cohosh"
                    },
                    {
                        "drugbank-id": "DB14009",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Medical Cannabis"
                    },
                    {
                        "drugbank-id": "DB14635",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Curcumin sulfate"
                    },
                    {
                        "drugbank-id": "DB00627",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Niacin"
                    },
                    {
                        "drugbank-id": "DB01104",
                        "description": "The metabolism of Sertraline can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01142",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Doxepin"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Methylene blue"
                    },
                    {
                        "drugbank-id": "DB00454",
                        "description": "The metabolism of Meperidine can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00532",
                        "description": "The metabolism of Mephenytoin can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB12930",
                        "description": "The metabolism of Opipramol can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB14881",
                        "description": "The metabolism of Oliceridine can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00751",
                        "description": "The metabolism of Epinastine can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB11718",
                        "description": "The metabolism of Encorafenib can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB12500",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Fedratinib"
                    },
                    {
                        "drugbank-id": "DB00530",
                        "description": "The metabolism of Erlotinib can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00675",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Tamoxifen"
                    },
                    {
                        "drugbank-id": "DB11963",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Dacomitinib"
                    },
                    {
                        "drugbank-id": "DB05109",
                        "description": "The metabolism of Trabectedin can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB08901",
                        "description": "The metabolism of Ponatinib can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01100",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Pimozide"
                    },
                    {
                        "drugbank-id": "DB00277",
                        "description": "The metabolism of Theophylline can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00637",
                        "description": "The metabolism of Astemizole can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB13874",
                        "description": "The metabolism of Enasidenib can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00321",
                        "description": "The metabolism of Amitriptyline can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01242",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Clomipramine"
                    },
                    {
                        "drugbank-id": "DB00540",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Nortriptyline"
                    },
                    {
                        "drugbank-id": "DB00543",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Amoxapine"
                    },
                    {
                        "drugbank-id": "DB00726",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Trimipramine"
                    },
                    {
                        "drugbank-id": "DB00575",
                        "description": "The metabolism of Clonidine can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00022",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Peginterferon alfa 2b"
                    },
                    {
                        "drugbank-id": "DB00209",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Trospium"
                    },
                    {
                        "drugbank-id": "DB00494",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Entacapone"
                    },
                    {
                        "drugbank-id": "DB00623",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Fluphenazine"
                    },
                    {
                        "drugbank-id": "DB01131",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Proguanil"
                    },
                    {
                        "drugbank-id": "DB00227",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Lovastatin"
                    },
                    {
                        "drugbank-id": "DB00234",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Reboxetine"
                    },
                    {
                        "drugbank-id": "DB00338",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Omeprazole"
                    },
                    {
                        "drugbank-id": "DB00361",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Vinorelbine"
                    },
                    {
                        "drugbank-id": "DB00448",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Lansoprazole"
                    },
                    {
                        "drugbank-id": "DB00570",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Vinblastine"
                    },
                    {
                        "drugbank-id": "DB01129",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Rabeprazole"
                    },
                    {
                        "drugbank-id": "DB01323",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with St John s Wort"
                    },
                    {
                        "drugbank-id": "DB01628",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Etoricoxib"
                    },
                    {
                        "drugbank-id": "DB04938",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Ospemifene"
                    },
                    {
                        "drugbank-id": "DB06287",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Temsirolimus"
                    },
                    {
                        "drugbank-id": "DB06700",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Desvenlafaxine"
                    },
                    {
                        "drugbank-id": "DB09065",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Cobicistat"
                    },
                    {
                        "drugbank-id": "DB11837",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Osilodrostat"
                    },
                    {
                        "drugbank-id": "DB04911",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Oritavancin"
                    },
                    {
                        "drugbank-id": "DB00489",
                        "description": "The metabolism of Sotalol can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01035",
                        "description": "The metabolism of Procainamide can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01195",
                        "description": "The metabolism of Flecainide can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00184",
                        "description": "The risk or severity of adverse effects can be increased when Nicotine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00396",
                        "description": "The risk or severity of adverse effects can be increased when Progesterone is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00536",
                        "description": "The risk or severity of adverse effects can be increased when Guanidine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00590",
                        "description": "The risk or severity of adverse effects can be increased when Doxazosin is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00728",
                        "description": "The risk or severity of adverse effects can be increased when Rocuronium is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00758",
                        "description": "The risk or severity of adverse effects can be increased when Clopidogrel is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00787",
                        "description": "The risk or severity of adverse effects can be increased when Acyclovir is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00914",
                        "description": "The risk or severity of adverse effects can be increased when Phenformin is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00917",
                        "description": "The risk or severity of adverse effects can be increased when Dinoprostone is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00925",
                        "description": "The risk or severity of adverse effects can be increased when Phenoxybenzamine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01004",
                        "description": "The risk or severity of adverse effects can be increased when Ganciclovir is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01032",
                        "description": "The risk or severity of adverse effects can be increased when Probenecid is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01337",
                        "description": "The risk or severity of adverse effects can be increased when Pancuronium is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB09073",
                        "description": "The risk or severity of adverse effects can be increased when Palbociclib is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00127",
                        "description": "The risk or severity of adverse effects can be increased when Dexchlorpheniramine maleate is combined with Spermine"
                    },
                    {
                        "drugbank-id": "DB00152",
                        "description": "The risk or severity of adverse effects can be increased when Dexchlorpheniramine maleate is combined with Thiamine"
                    },
                    {
                        "drugbank-id": "DB00987",
                        "description": "The risk or severity of adverse effects can be increased when Dexchlorpheniramine maleate is combined with Cytarabine"
                    },
                    {
                        "drugbank-id": "DB01199",
                        "description": "The risk or severity of adverse effects can be increased when Dexchlorpheniramine maleate is combined with Tubocurarine"
                    },
                    {
                        "drugbank-id": "DB03128",
                        "description": "The risk or severity of adverse effects can be increased when Dexchlorpheniramine maleate is combined with Acetylcholine"
                    },
                    {
                        "drugbank-id": "DB03566",
                        "description": "The risk or severity of adverse effects can be increased when Dexchlorpheniramine maleate is combined with Spermidine"
                    },
                    {
                        "drugbank-id": "DB04830",
                        "description": "The risk or severity of adverse effects can be increased when Dexchlorpheniramine maleate is combined with Buformin"
                    },
                    {
                        "drugbank-id": "DB13952",
                        "description": "The risk or severity of adverse effects can be increased when Estradiol acetate is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB13953",
                        "description": "The risk or severity of adverse effects can be increased when Estradiol benzoate is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB13954",
                        "description": "The risk or severity of adverse effects can be increased when Estradiol cypionate is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB13955",
                        "description": "The risk or severity of adverse effects can be increased when Estradiol dienanthate is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB13956",
                        "description": "The risk or severity of adverse effects can be increased when Estradiol valerate is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00863",
                        "description": "The risk or severity of adverse effects can be increased when Dexchlorpheniramine maleate is combined with Ranitidine"
                    },
                    {
                        "drugbank-id": "DB00661",
                        "description": "The risk or severity of adverse effects can be increased when Verapamil is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00224",
                        "description": "The risk or severity of adverse effects can be increased when Indinavir is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01018",
                        "description": "The risk or severity of adverse effects can be increased when Guanfacine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00463",
                        "description": "The therapeutic efficacy of Metharbital can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00653",
                        "description": "The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00740",
                        "description": "The therapeutic efficacy of Riluzole can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00832",
                        "description": "The therapeutic efficacy of Phensuximide can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00837",
                        "description": "The therapeutic efficacy of Progabide can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01080",
                        "description": "The therapeutic efficacy of Vigabatrin can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01121",
                        "description": "The therapeutic efficacy of Phenacemide can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01511",
                        "description": "The therapeutic efficacy of Delorazepam can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB02207",
                        "description": "The therapeutic efficacy of 7 Nitroindazole can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB04165",
                        "description": "The therapeutic efficacy of Valpromide can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB06512",
                        "description": "The therapeutic efficacy of Deramciclane can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB06527",
                        "description": "The therapeutic efficacy of Tramiprosate can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB06554",
                        "description": "The therapeutic efficacy of Gaboxadol can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB08329",
                        "description": "The therapeutic efficacy of Sulthiame can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB08954",
                        "description": "The therapeutic efficacy of Ifenprodil can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB09011",
                        "description": "The therapeutic efficacy of Beclamide can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB09117",
                        "description": "The therapeutic efficacy of Paraldehyde can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB11549",
                        "description": "The therapeutic efficacy of Tiletamine can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB11859",
                        "description": "The therapeutic efficacy of Brexanolone can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB11868",
                        "description": "The therapeutic efficacy of Etiracetam can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB12338",
                        "description": "The therapeutic efficacy of Carisbamate can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB13362",
                        "description": "The therapeutic efficacy of Pheneturide can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB13396",
                        "description": "The therapeutic efficacy of Neocitrullamon can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB13437",
                        "description": "The therapeutic efficacy of Medazepam can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB13455",
                        "description": "The therapeutic efficacy of Phenibut can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB13799",
                        "description": "The therapeutic efficacy of Ethadione can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB14050",
                        "description": "The therapeutic efficacy of Cannabidivarin can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB15203",
                        "description": "The therapeutic efficacy of JNJ 26489112 can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00996",
                        "description": "The therapeutic efficacy of Gabapentin can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01202",
                        "description": "The therapeutic efficacy of Levetiracetam can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01355",
                        "description": "The therapeutic efficacy of Hexobarbital can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00186",
                        "description": "The therapeutic efficacy of Lorazepam can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00241",
                        "description": "The therapeutic efficacy of Butalbital can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00252",
                        "description": "The therapeutic efficacy of Phenytoin can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00273",
                        "description": "The therapeutic efficacy of Topiramate can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00312",
                        "description": "The therapeutic efficacy of Pentobarbital can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00418",
                        "description": "The therapeutic efficacy of Secobarbital can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00474",
                        "description": "The therapeutic efficacy of Methohexital can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00564",
                        "description": "The therapeutic efficacy of Carbamazepine can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00599",
                        "description": "The therapeutic efficacy of Thiopental can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00617",
                        "description": "The therapeutic efficacy of Paramethadione can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00628",
                        "description": "The therapeutic efficacy of Clorazepic acid can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00754",
                        "description": "The therapeutic efficacy of Ethotoin can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00776",
                        "description": "The therapeutic efficacy of Oxcarbazepine can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00794",
                        "description": "The therapeutic efficacy of Primidone can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00819",
                        "description": "The therapeutic efficacy of Acetazolamide can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00829",
                        "description": "The therapeutic efficacy of Diazepam can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00849",
                        "description": "The therapeutic efficacy of Methylphenobarbital can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00906",
                        "description": "The therapeutic efficacy of Tiagabine can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00962",
                        "description": "The therapeutic efficacy of Zaleplon can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01068",
                        "description": "The therapeutic efficacy of Clonazepam can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01154",
                        "description": "The therapeutic efficacy of Thiamylal can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01174",
                        "description": "The therapeutic efficacy of Phenobarbital can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01215",
                        "description": "The therapeutic efficacy of Estazolam can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01320",
                        "description": "The therapeutic efficacy of Fosphenytoin can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01351",
                        "description": "The therapeutic efficacy of Amobarbital can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01483",
                        "description": "The therapeutic efficacy of Barbital can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB01595",
                        "description": "The therapeutic efficacy of Nitrazepam can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB05541",
                        "description": "The therapeutic efficacy of Brivaracetam can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB06201",
                        "description": "The therapeutic efficacy of Rufinamide can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB06218",
                        "description": "The therapeutic efficacy of Lacosamide can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB06458",
                        "description": "The therapeutic efficacy of Remacemide can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB06470",
                        "description": "The therapeutic efficacy of Clomethiazole can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB08883",
                        "description": "The therapeutic efficacy of Perampanel can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB09001",
                        "description": "The therapeutic efficacy of Barbexaclone can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB09119",
                        "description": "The therapeutic efficacy of Eslicarbazepine acetate can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB11400",
                        "description": "The therapeutic efficacy of Doramectin can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB12131",
                        "description": "The therapeutic efficacy of Vinpocetine can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB14575",
                        "description": "The therapeutic efficacy of Eslicarbazepine can be decreased when used in combination with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB11640",
                        "description": "The risk or severity of seizure can be increased when Dexchlorpheniramine maleate is combined with Amifampridine"
                    },
                    {
                        "drugbank-id": "DB00005",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be increased when combined with Etanercept"
                    },
                    {
                        "drugbank-id": "DB00026",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be increased when combined with Anakinra"
                    },
                    {
                        "drugbank-id": "DB00051",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be increased when combined with Adalimumab"
                    },
                    {
                        "drugbank-id": "DB00065",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be increased when combined with Infliximab"
                    },
                    {
                        "drugbank-id": "DB01281",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be increased when combined with Abatacept"
                    },
                    {
                        "drugbank-id": "DB04956",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be increased when combined with Afelimomab"
                    },
                    {
                        "drugbank-id": "DB05676",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be increased when combined with Apremilast"
                    },
                    {
                        "drugbank-id": "DB06168",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be increased when combined with Canakinumab"
                    },
                    {
                        "drugbank-id": "DB06273",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be increased when combined with Tocilizumab"
                    },
                    {
                        "drugbank-id": "DB06372",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be increased when combined with Rilonacept"
                    },
                    {
                        "drugbank-id": "DB06674",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be increased when combined with Golimumab"
                    },
                    {
                        "drugbank-id": "DB08904",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be increased when combined with Certolizumab pegol"
                    },
                    {
                        "drugbank-id": "DB09029",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be increased when combined with Secukinumab"
                    },
                    {
                        "drugbank-id": "DB09036",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be increased when combined with Siltuximab"
                    },
                    {
                        "drugbank-id": "DB14724",
                        "description": "The metabolism of Dexchlorpheniramine maleate can be increased when combined with Emapalumab"
                    },
                    {
                        "drugbank-id": "DB00515",
                        "description": "The serum concentration of Cisplatin can be increased when it is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00526",
                        "description": "The serum concentration of Oxaliplatin can be increased when it is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00631",
                        "description": "The serum concentration of Clofarabine can be increased when it is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00656",
                        "description": "The risk or severity of QTc prolongation can be increased when Trazodone is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB11986",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Entrectinib"
                    },
                    {
                        "drugbank-id": "DB12825",
                        "description": "Lefamulin may increase the QTc prolonging activities of Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB06637",
                        "description": "The risk or severity of seizure can be increased when Dexchlorpheniramine maleate is combined with Dalfampridine"
                    },
                    {
                        "drugbank-id": "DB01175",
                        "description": "The serum concentration of Escitalopram can be increased when it is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB04855",
                        "description": "The metabolism of Dronedarone can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB15066",
                        "description": "The serum concentration of Dexchlorpheniramine maleate can be increased when it is combined with Givosiran"
                    },
                    {
                        "drugbank-id": "DB01156",
                        "description": "The risk or severity of seizure can be increased when Bupropion is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB06119",
                        "description": "The serum concentration of Cenobamate can be decreased when it is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00243",
                        "description": "The serum concentration of Dexchlorpheniramine maleate can be increased when it is combined with Ranolazine"
                    },
                    {
                        "drugbank-id": "DB00557",
                        "description": "The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00246",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Ziprasidone"
                    },
                    {
                        "drugbank-id": "DB00503",
                        "description": "The serum concentration of Dexchlorpheniramine maleate can be increased when it is combined with Ritonavir"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "The risk or severity of QTc prolongation can be increased when Haloperidol is combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB11652",
                        "description": "The metabolism of Tucatinib can be decreased when combined with Dexchlorpheniramine maleate"
                    },
                    {
                        "drugbank-id": "DB00472",
                        "description": "The serum concentration of Dexchlorpheniramine maleate can be increased when it is combined with Fluoxetine"
                    },
                    {
                        "drugbank-id": "DB11932",
                        "description": "The serum concentration of Dexchlorpheniramine maleate can be increased when it is combined with Abametapir"
                    },
                    {
                        "drugbank-id": "DB15762",
                        "description": "The serum concentration of Dexchlorpheniramine maleate can be decreased when it is combined with Satralizumab"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}